EU General Court sides with Merck in TM opposition

A German individual has lost an appeal before the tribunal of the EU General Court, after his trademark registration was opposed by Merck.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

Chiesi blocks Japanese drugmaker’s new brand at EU General Court

1 July 2020 Japan-based Nitto Pharmaceutical Industries has been blocked from using its ‘Noster’ brand in the EU, in a win for Italian drugmaker Chiesi Farmaceutici.

Big Pharma

Monster falls short in Merck TM dispute

9 June 2020 Monster Energy has failed to block a UK trademark filed by German pharmaceutical company Merck KGaA.

Europe

Merck and Evotec strike CRISPR licensing deal

14 November 2019 Merck has agreed to license its CRISPR gene-editing technology to German biotech company Evotec.

More on this story

Big Pharma

Chiesi blocks Japanese drugmaker’s new brand at EU General Court

1 July 2020 Japan-based Nitto Pharmaceutical Industries has been blocked from using its ‘Noster’ brand in the EU, in a win for Italian drugmaker Chiesi Farmaceutici.

Big Pharma

Monster falls short in Merck TM dispute

9 June 2020 Monster Energy has failed to block a UK trademark filed by German pharmaceutical company Merck KGaA.

Europe

Merck and Evotec strike CRISPR licensing deal

14 November 2019 Merck has agreed to license its CRISPR gene-editing technology to German biotech company Evotec.

More on this story

Big Pharma

Chiesi blocks Japanese drugmaker’s new brand at EU General Court

1 July 2020 Japan-based Nitto Pharmaceutical Industries has been blocked from using its ‘Noster’ brand in the EU, in a win for Italian drugmaker Chiesi Farmaceutici.

Big Pharma

Monster falls short in Merck TM dispute

9 June 2020 Monster Energy has failed to block a UK trademark filed by German pharmaceutical company Merck KGaA.

Europe

Merck and Evotec strike CRISPR licensing deal

14 November 2019 Merck has agreed to license its CRISPR gene-editing technology to German biotech company Evotec.